Chromogranin B: Intra- and extra-cellular mechanisms to regulate catecholamine storage and release, in catecholaminergic cells and organisms

Journal of Neurochemistry

Volumn 129, Issue 1, 2014, Pages 48-59

  Zhang, Kuixing ^a,b   Biswas, Nilima ^a,b   Gayen, Jiaur R ^a,b   Miramontes Gonzalez, Jose Pablo ^a,b,c   Hightower, C Makena ^a,b   Mustapic, Maja ^a,b   Mahata, Manjula ^a,b   Huang, Chun Teng ^a,b   Hook, Vivian Y ^a,b   Mahata, Sushil K ^a,b   Vaingankar, Sucheta ^a,b   O'Connor, Daniel T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

adrenal; catecholamines; chromaffin; chromogranin B; hypertension

Indexed keywords

ADRENALIN; CATECHOLAMINE; CHROMOGRANIN B; LENTIVIRUS VECTOR; NICOTINE; NORADRENALIN; SMALL INTERFERING RNA;

ADRENAL MEDULLA; ADRENALIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE NERVE CELL; CATECHOLAMINE RELEASE; CATECHOLAMINE UPTAKE; CHROMAFFIN CELL; CHROMAFFIN GRANULE; CONTROLLED STUDY; EXOCYTOSIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SECRETORY GRANULE; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY;

LENTIVIRUS; MUS;

ADRENAL; CATECHOLAMINES; CHROMAFFIN; CHROMOGRANIN B; HYPERTENSION;

AMINO ACID SEQUENCE; ANIMALS; CATECHOLAMINES; CHROMAFFIN GRANULES; CHROMOGRANIN B; EXTRACELLULAR FLUID; HUMANS; INTRACELLULAR FLUID; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; RATS;

EID: 84897111882     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12527     Document Type: Article

References (46)

1. Binder A., (2007) A review of the genetics of essential hypertension. Curr. Opin. Cardiol. 22, 176-184.
2. Biswas N., Vaingankar S. M., Mahata M., et al,. (2008) Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin. Endocrinology 149, 749-757.
3. Conlon J. M., Hamberger B., and, Grimelius L., (1992) Isolation of peptides arising from the specific posttranslational processing of chromogranin A and chromogranin B from human pheochromocytoma tissue. Peptides 13, 639-644.
4. Courel M., Rodemer C., Nguyen S. T., et al,. (2006) Secretory granule biogenesis in sympathoadrenal cells: identification of a granulogenic determinant in the secretory prohormone chromogranin A. J. Biol. Chem. 281, 38038-38051.
5. Diaz-Vera J., Morales Y. G., Hernandez-Fernaud J. R., et al,. (2010) Chromogranin B gene ablation reduces the catecholamine cargo and decelerates exocytosis in chromaffin secretory vesicles. J. Neurosci. 30, 950-957.
6. Falkensammer G., Fischer-Colbrie R., and, Winkler H., (1985) Biogenesis of chromaffin granules: incorporation of sulfate into chromogranin B and into a proteoglycan. J. Neurochem. 45, 1475-1480.
7. Gill B. M., Barbosa J. A., Dinh T. Q., Garrod S., Chromogranin O' Connor D. T., and, B, (1991) isolation from pheochromocytoma, N-terminal sequence, tissue distribution and secretory vesicle processing. Regul. Pept. 33, 223-235.
8. Greenwood T. A., Cadman P. E., Stridsberg M., et al,. (2004) Genome-wide linkage analysis of chromogranin B expression in the CEPH pedigrees: implications for exocytotic sympathochromaffin secretion in humans. Physiol. Genomics 18, 119-127.
9. Greenwood T. A., Rao F., Stridsberg M., et al,. (2006) Pleiotropic effects of novel trans-acting loci influencing human sympathochromaffin secretion. Physiol. Genomics 25, 470-479.
10. Gupta N., Bark S. J., Lu W. D., et al,. (2010) Mass spectrometry-based neuropeptidomics of secretory vesicles from human adrenal medullary pheochromocytoma reveals novel peptide products of prohormone processing. J. Proteome Res. 9, 5065-5075.
11. Helle K. B., Reed R. K., Pihl K. E., and, Serck-Hanssen G., (1985) Osmotic properties of the chromogranins and relation to osmotic pressure in catecholamine storage granules. Acta Physiol. Scand. 123, 21-33.
12. Hook V., Bark S., Gupta N., et al,. (2010) Neuropeptidomic components generated by proteomic functions in secretory vesicles for cell-cell communication. AAPS J. 12, 635-645.
13. Huh Y. H., Jeon S. H., and, Yoo S. H., (2003) Chromogranin B-induced secretory granule biogenesis: comparison with the similar role of chromogranin A. J. Biol. Chem. 278, 40581-40589.
14. Huttner W. B., Gerdes H. H., and, Rosa P., (1991) The granin (chromogranin/secretogranin) family. Trends Biochem. Sci. 16, 27-30.
15. Jiang Q., Taupenot L., Mahata S. K., et al,. (2001) Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release. J. Biol. Chem. 276, 25022-25029.
16. Karlsson E., Stridsberg M., and, Sandler S., (2000) Chromogranin-B regulation of IAPP and insulin secretion. Regul. Pept. 87, 33-39.
17. Kennedy B. P., Mahata S. K., O'Connor D. T., and, Ziegler M. G., (1998) Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo. Peptides 19, 1241-1248.
18. Landen M., Grenfeldt B., Davidsson P., et al,. (1999) Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia. Eur. Neuropsychopharmacol. 9, 311-315.
19. Lillie E. O., and, O'Connor D. T., (2006) Early phenotypic changes in hypertension: a role for the autonomic nervous system and heredity. Hypertension 47, 331-333.
20. Mahapatra N. R., O'Connor D. T., Vaingankar S. M., et al,. (2005) Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J. Clin. Invest. 115, 1942-1952.
21. Mahata S. K., Mahata M., Parmer R. J., and, O'Connor D. T., (1999) Desensitization of catecholamine release. The novel catecholamine release-inhibitory peptide catestatin (chromogranin a344-364) acts at the receptor to prevent nicotinic cholinergic tolerance. J. Biol. Chem. 274, 2920-2928.
22. Marksteiner J., Lechner T., Kaufmann W. A., et al,. (2000) Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's disease. Acta Neuropathol. 100, 205-212.
23. Marksteiner J., Kaufmann W. A., Gurka P., and, Humpel C., (2002) Synaptic proteins in Alzheimer's disease. J. Mol. Neurosci. 18, 53-63.
24. Montero-Hadjadje M., Elias S., Chevalier L., et al,. (2009) Chromogranin A promotes peptide hormone sorting to mobile granules in constitutively and regulated secreting cells: role of conserved N- and C-terminal peptides. J. Biol. Chem. 284, 12420-12431.
25. Mosley C. A., Taupenot L., Biswas N., et al,. (2007) Biogenesis of the secretory granule: chromogranin A coiled-coil structure results in unusual physical properties and suggests a mechanism for granule core condensation. Biochemistry 46, 10999-11012.
26. Natori S., and, Huttner W. B., (1996) Chromogranin B (secretogranin I) promotes sorting to the regulated secretory pathway of processing intermediates derived from a peptide hormone precursor. Proc. Natl Acad. Sci. USA 93, 4431-4436.
27. O'Connor D. T., Frigon R. P., and, Sokoloff R. L., (1984) Human chromogranin A. Purification and characterization from catecholamine storage vesicles of human pheochromocytoma. Hypertension 6, 2-12.
28. O'Connor D. T., Klein R. L., Thureson-Klein A. K., Chromogranin Barbosa J. A., and, A, (1991) localization and stoichiometry in large dense core catecholamine storage vesicles from sympathetic nerve. Brain Res. 567, 188-196.
29. O'Connor D. T., Takiyyuddin M. A., Printz M. P., et al,. (1999) Catecholamine storage vesicle protein expression in genetic hypertension. Blood Press. 8, 285-295.
30. Parmer R. J., Mahata M., Gong Y., et al,. (2000) Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion. J. Clin. Invest. 106, 907-915.
31. Rao F., Wen G., Gayen J. R., et al,. (2007) Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation 115, 2271-2281.
32. Rosa P., Hille A., Lee R. W., Zanini A., De Camilli P., and, Huttner W. B., (1985) Secretogranins I and II: two tyrosine-sulfated secretory proteins common to a variety of cells secreting peptides by the regulated pathway. J. Cell Biol. 101, 1999-2011.
33. Schober M., Fischer-Colbrie R., Schmid K. W., Bussolati G., O'Connor D. T., and, Winkler H., (1987) Comparison of chromogranins A, B, and secretogranin II in human adrenal medulla and pheochromocytoma. Lab. Invest. 57, 385-391.
34. Schober M., Howe P. R., Sperk G., Fischer-Colbrie R., and, Winkler H., (1989) An increased pool of secretory hormones and peptides in adrenal medulla of stroke-prone spontaneously hypertensive rats. Hypertension 13, 469-474.
35. Strub J. M., Garcia-Sablone P., Lonning K., et al,. (1995) Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity. Eur. J. Biochem. 229, 356-368.
36. Takiyyuddin M. A., De Nicola L., Gabbai F. B., et al,. (1993) Catecholamine secretory vesicles. Augmented chromogranins and amines in secondary hypertension. Hypertension 21, 674-679.
37. Taupenot L., Harper K. L., and, O'Connor D. T., (2003) The chromogranin-secretogranin family. N. Engl. J. Med. 348, 1134-1149.
38. Taylor C. V., Taupenot L., Mahata S. K., et al,. (2000) Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules. J. Biol. Chem. 275, 22905-22915.
39. Tiscornia G., Singer O., and, Verma I. M., (2006) Production and purification of lentiviral vectors. Nat. Protoc. 1, 241-245.
40. Videen J. S., Mezger M. S., Chang Y. M., and, O'Connor D. T., (1992) Calcium and catecholamine interactions with adrenal chromogranins. Comparison of driving forces in binding and aggregation. J. Biol. Chem. 267, 3066-3073.
41. Wegrzyn J. L., Bark S. J., Funkelstein L., et al,. (2010) Proteomics of dense core secretory vesicles reveal distinct protein categories for secretion of neuroeffectors for cell-cell communication. J. Proteome Res. 9, 5002-5024.
42. Winkler H., Laslop A., Leitner B., and, Weiss C., (1998) The secretory cocktail of adrenergic large dense-core vesicles: the functional role of the chromogranins. Adv. Pharmacol. 42, 257-259.
43. Yoo S. H., and, Jeon C. J., (2000) Inositol 1,4,5-trisphosphate receptor/Ca2+ channel modulatory role of chromogranin A, a Ca2+ storage protein of secretory granules. J. Biol. Chem. 275, 15067-15073.
44. Zhang K., Rao F., Rana B. K., et al,. (2009) Autonomic function in hypertension: role of genetic variation at the catecholamine storage vesicle protein chromogranin B (CHGB). Circ. Cardiovasc. Genet. 2, 46-56.
45. Zhang K., Rao F., Wang L., et al,. (2010) Common functional genetic variants in catecholamine storage vesicle protein promoter motifs interact to trigger systemic hypertension. J. Am. Coll. Cardiol. 55, 1463-1475.
46. Zhang K., Chen Y., Wen G., et al,. (2011) Catecholamine storage vesicles: role of core protein genetic polymorphisms in hypertension. Curr. Hypertens. Rep. 13, 36-45.